ADMA

ADMA BIOLOGICS, INC.

NasdaqHealthcareBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Insider activity for last month from Oct 16 to Nov 16.

How these metrics are calculated

Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.

Total buying$00 buys
Total selling$1.76M2 sales
Net open-market−$1.76MBuying minus selling
Active insiders1Distinct reporting owners

ADMA transaction history

Newest filings · 20 transactions per page

Latest insider transactions

Form 4 filings from last month.
Newest company filings
InsiderActivityDisclosed valueFiled (ET)
Grossman Adam S
President
PRES
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
Derivative securitySEC filing ↗
$0View disclosure →
Grossman Adam S
President
PRES
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Large sale
A sale above $1.0M, or above twice the company’s median insider trade with at least three prior trades in the sample.
Repeat seller
The same owner reported more than one sale within 30 days.
+1
Pre-planned (10b5-1)

10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.

SEC filing ↗
−$504kView disclosure →
Grossman Adam S
President
PRES
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Large sale
A sale above $1.0M, or above twice the company’s median insider trade with at least three prior trades in the sample.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
SEC filing ↗
−$1.26MView disclosure →
Grossman Adam S
President
PRES
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
SEC filing ↗
$567kView disclosure →

Insider activity report

Calendar-month buckets within the selected date range

Latest filing: Nov 5, 2026

Open-market transaction mix · 2 transactions in the selected period
0 buys0%·100%2 sells

Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.

View exact monthly counts and disclosed values
Monthly activity within the selected period; unknown values remain unknown.
MonthBuysSellsAwards (A)Buy valueSell valueNet P/S value
Oct 2026000$0$0$0
Nov 2026020$0$1,764,000−$1,764,000

Distinct insiders active

Reporting-owner CIKs by month · peak Nov 2026 (1)
Oct 2026: 0 insidersNov 2026: 1 insiders
Oct 2026Nov 2026
1distinct insiders in selected period
Largest insider activity
By absolute net disclosed value · current transaction page
1 insider
  • GS
    Grossman Adam SPRES · 0 buys · 2 sales · 0 awards (A)
    −$1.20Mlast Nov 5
Filing, role and holdings details

Filing-only signals

Deterministic matches in the selected period

Recent filing activity
Most recent 4 transactions on this page · color = transaction code

Filing detail checks

Secondary metrics for the selected period
Largest buy—
Largest sale$1.26M
10b5-1 detected4
Amended rows0

Transaction codes

By Form 4 transaction code in selected period
4transactionstxns
  • M · Option exercise · dominant2 · 50%
  • S · Open-market sells2 · 50%

Activity by reported role

A joint filing can contribute to multiple roles
PRES4

Reported Holdings After

Separated by insider, security, and ownership type

Grossman Adam SCommon Stock · Direct
2.22M2.07MNov 5, 2026Nov 5, 2026
2,070,777Nov 5, 2026
Grossman Adam SStock Option (Right to Buy) · Direct
586k586kNov 5, 2026Nov 5, 2026
585,950Nov 5, 2026

These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.

Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells red
1 active days
Oct 16 → Nov 16
LessMore

ADMA BIOLOGICS, INC. Insider Activity FAQ

SEC Form 4 context

Who recently reported transactions at ADMA BIOLOGICS, INC.?

Grossman Adam S.

When was the latest reported open-market purchase?

No code-P purchase is available for this period.

When was the latest reported open-market sale?

Grossman Adam S reported a sale on Nov 5, 2026 valued at $504k. Read the SEC filing.

What is the recent purchase and sale balance?

Net open-market selling in the selected period was $1,764,000. Sales can occur for many non-investment reasons.

Where can I see the original SEC filing?

Every transaction row and latest-activity fact links to its original SEC filing.

What do these Form 4 transaction codes mean?

P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.